The physiological basis of complementary and alternative medicines for polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is characterized by chronic hyperandrogenic anovulation leading to symptoms of hirsutism, acne, irregular menses, and infertility. Multiple metabolic and cardiovascular risk factors are associated with PCOS, including insulin resistance, obesity, type 2 diabetes, hypertension, inflammation, and subclinical atherosclerosis. However, current treatments for PCOS are only moderately effective at controlling symptoms and preventing complications. This article describes how the physiological effects of major complementary and alternative medicine (CAM) treatments could reduce the severity of PCOS and its complications. Acupuncture reduces hyperandrogenism and improves menstrual frequency in PCOS. Acupuncture's clinical effects are mediated via activation of somatic afferent nerves innervating the skin and muscle, which, via modulation of the activity in the somatic and autonomic nervous system, may modulate endocrine and metabolic functions in PCOS. Chinese herbal medicines and dietary supplements may also exert beneficial physiological effects in PCOS, but there is minimal evidence that these CAM treatments are safe and effective. Mindfulness has not been investigated in PCOS, but it has been shown to reduce psychological distress and exert positive effects on the central and autonomic nervous systems, hypothalamic-pituitary-adrenal axis, and immune system, leading to reductions in blood pressure, glucose, and inflammation. In conclusion, CAM treatments may have beneficial endocrine, cardiometabolic, and reproductive effects in PCOS. However, most studies of CAM treatments for PCOS are small, nonrandomized, or uncontrolled. Future well-designed studies are needed to further evaluate the safety, effectiveness, and mechanisms of CAM treatments for PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unconventional medicine in the United States-Prevalence, costs, and patterns of use
Eisenberg, D. M., Kessler, R. C., Foster, C., Norlock, F. E., Calkins, D. R., & Delbanco, T. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280406 · Cited by 4,177 · cited 10×
“In conclusion, several CAM treatments may have beneficial endocrine, cardiometabolic, and reproductive effects in women with PCOS.”
BackgroundInfluentialAlterations in brain and immune function produced by mindfulness meditation
Davidson, R. J., Kabat-Zinn, J., Schumacher, J., Rosenkranz, M., Muller, D., Santorelli, S. F., Urbanowski, F., Harrington, A., Bonus, K., & Sheridan, J. F. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000077505.67574.e3 · Cited by 2,925 · cited 1×
“These physiological effects appear to be mediated by changes in brain activity (18, 31) and structure (40, 60) leading to improvements in the autonomic nervous system (57, 81, 106) and hypothalamic-pituitary-adrenal (HPA) axis (9, 77, 115).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 2×
“Multiple metabolic and cardiovascular risk factors are associated with PCOS, including insulin resistance (IR), obesity, type 2 diabetes (DM-2), hypertension, dyslipidemia, inflammation, and subclinical cardiovascular disease (32, 62, 63, 87, 107).”
BackgroundSelf-citationMeditation experience is associated with increased cortical thickness
Lazar, S. W., Kerr, C. E., Wasserman, R. H., Gray, J. R., Greve, D. N., Treadway, M. T., McGarvey, M., Quinn, B. T., Dusek, J. A., Benson, H., et al. (2005) · NeuroReport · doi:10.1097/01.wnr.0000186598.66243.19 · Cited by 1,698
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Self-citationGoldin, P. R., & Gross, J. J. (2010) · Emotion · doi:10.1037/a0018441 · Cited by 1,242 · cited 1×
“These physiological effects appear to be mediated by changes in brain activity (18, 31) and structure (40, 60) leading to improvements in the autonomic nervous system (57, 81, 106) and hypothalamic-pituitary-adrenal (HPA) axis (9, 77, 115).”
BackgroundComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196 · cited 1×
“Acupuncture treatment is associated with particularly potent placebo effects, and there are indications that acupuncture treatment may be associated with larger effects than pharmacological and other physical placebos (52, 53, 67).”
BackgroundLudwig, D. S. (2008) · JAMA · doi:10.1001/jama.300.11.1350 · Cited by 957
A systematic review of neurobiological and clinical features of mindfulness meditations
Chiesa, A., & Serretti, A. (2010) · Psychological Medicine · doi:10.1017/s0033291709991747 · Cited by 749
Carlson, L. E., Speca, M., Faris, P., & Patel, K. D. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.04.002 · Cited by 688 · cited 2×
“Mindfulness-based stress reduction (MBSR), the most researched mindfulness-based program, reduces psychological distress (71) and may also reduce blood pressure, glucose, and inflammation (9, 77, 89, 115).”
BackgroundPrevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00948-2 · Cited by 622 · cited 1×
“Multiple metabolic and cardiovascular risk factors are associated with PCOS, including insulin resistance (IR), obesity, type 2 diabetes (DM-2), hypertension, dyslipidemia, inflammation, and subclinical cardiovascular disease (32, 62, 63, 87, 107).”
BackgroundSelf-citationAnderson, R. A., Broadhurst, C. L., Polansky, M. M., Schmidt, W. F., Khan, A., Flanagan, V. P., Schoene, N. W., & Graves, D. J. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034916b · Cited by 561 · cited 1×
“Cinnamon extract (a traditional herb) has been shown to potentiate the insulin effect through upregulation of glucose uptake in cultured adipocytes (3, 8, 43).”
BackgroundInvestigation of mindfulness meditation practitioners with voxel-based morphometry
Hölzel, B. K., Ott, U., Gard, T., Hempel, H., Weygandt, M., Morgen, K., & Vaitl, D. (2008) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsm038 · Cited by 542 · cited 1×
“These physiological effects appear to be mediated by changes in brain activity (18, 31) and structure (40, 60) leading to improvements in the autonomic nervous system (57, 81, 106) and hypothalamic-pituitary-adrenal (HPA) axis (9, 77, 115).”
BackgroundWitek-Janusek, L., Albuquerque, K., Chroniak, K. R., Chroniak, C., Durazo-Arvizu, R., & Mathews, H. L. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.01.012 · Cited by 506 · cited 2×
“Mindfulness-based stress reduction (MBSR), the most researched mindfulness-based program, reduces psychological distress (71) and may also reduce blood pressure, glucose, and inflammation (9, 77, 89, 115).”
BackgroundInsulin-like Biological Activity of Culinary and Medicinal Plant Aqueous Extracts in Vitro
Broadhurst, C. L., Polansky, M. M., & Anderson, R. A. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9904517 · Cited by 429 · cited 1×
“Cinnamon extract (a traditional herb) has been shown to potentiate the insulin effect through upregulation of glucose uptake in cultured adipocytes (3, 8, 43).”
BackgroundKubota, Y., Sato, W., Toichi, M., Murai, T., Okada, T., Hayashi, A., & Sengoku, A. (2001) · Cognitive Brain Research · doi:10.1016/s0926-6410(00)00086-0 · Cited by 369 · cited 1×
“These physiological effects appear to be mediated by changes in brain activity (18, 31) and structure (40, 60) leading to improvements in the autonomic nervous system (57, 81, 106) and hypothalamic-pituitary-adrenal (HPA) axis (9, 77, 115).”
BackgroundThe insular cortex and cardiovascular system: a new insight into the brain-heart axis
Nagai, M., Hoshide, S., & Kario, K. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.05.001 · Cited by 328
A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes
Jarvill-Taylor, K. J., Anderson, R. A., & Graves, D. J. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719053 · Cited by 324
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
Gilling‐Smith, C., Story, H., Rogers, V., & Franks, S. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2321049.x · Cited by 301 · cited 1×
“Ovarian hyperandrogenemia, the most consistent endocrine feature, probably plays a key role (30), but hyperinsulinemia/insulin resistance and abdominal obesity are also thought to be important (4).”
BackgroundQin, B., Nagasaki, M., Ren, M., Bajotto, G., Oshida, Y., & Sato, Y. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00173-6 · Cited by 298
Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation
Deeks, A. A., Gibson-Helm, M. E., & Teede, H. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.018 · Cited by 246
Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Sverrisdóttir, Y. B., Mogren, T., Kataoka, J., Janson, P. O., & Stener-Victorin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00725.2007 · Cited by 216
Self-citationStener-Victorin, E., Jedel, E., Janson, P. O., & Sverrisdottir, Y. B. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2009 · Cited by 194
Self-citationEvidence of proatherogenic inflammation in polycystic ovary syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.022 · Cited by 135 · cited 1×
“Multiple metabolic and cardiovascular risk factors are associated with PCOS, including insulin resistance (IR), obesity, type 2 diabetes (DM-2), hypertension, dyslipidemia, inflammation, and subclinical cardiovascular disease (32, 62, 63, 87, 107).”
BackgroundKasim-Karakas, S. E., Almario, R. U., Gregory, L., Wong, R., Todd, H., & Lasley, B. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030666 · Cited by 99
Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02955-2 · Cited by 62 · cited 1×
“Indeed, opioid receptor antagonists improve menstrual cyclicity, induce ovulation, and decrease testosterone, insulin, and LH levels and the LH/FSH ratio (1, 15, 28).”
BackgroundNaltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008) · Human Reproduction · doi:10.1093/humrep/den273 · Cited by 58 · cited 2×
“Effect of electro-acupuncture on ovarian expression of alpha(1)- and”
BackgroundEffects of tai chi exercise on patients with type 2 diabetes
Wang, J. H. (2008) · Medicine and Sport Science · doi:10.1159/000134303 · Cited by 33 · cited 10×
“Similarly, many of the CHMs used to treat DM-2 may be useful for PCOS.”
BackgroundInfluential
Cited by
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
“Acupuncture improves clinical manifestations of PCOS by activating somatic afferent nerves of the skin and muscles, modulating somatic and autonomic nervous system activity and endocrine/metabolic functions [91].”
BackgroundZhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Tremellen, K., & Pearce, K. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.016 · Cited by 359
“tics or symbiotic therapy as a treatment for PCOS [87].”
BackgroundLifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
Mindfulness‐Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial
Raja‐Khan, N., Agito, K., Shah, J., Stetter, C. M., Gustafson, T. S., Socolow, H., Kunselman, A. R., Reibel, D. K., & Legro, R. S. (2017) · Obesity · doi:10.1002/oby.21910 · Cited by 53
“Potential mechanisms by which MBSR could improve cardiometabolic outcomes include physiological changes in cortisol and catecholamines, psychological changes in depressive and anxiety symptoms, self-regulation, resilience, and coping, and behavioral changes in diet and physical activity (5,7,9,10).”
BackgroundSelf-citation
Metadata
- Authors
- Raja-Khan, N., Stener-Victorin, E., Wu, X., & Legro, R. S.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2011-07
- Volume
- 301
- Issue
- 1
- Pages
- E1-E10
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2148233846
- Cited by
- 86
- References
- 29
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.